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of submaximal doses of MEN16132 (1 lg/25 ll) and dexamethasone
(10–30 lg/25 ll), each producing a mean 20–25% inhibition of pain,
caused analgesia of about 40–45%, ascribable to the sum of the
respective antinociceptive effects.
Conclusion: Intra-articular combination of low doses of MEN16132
and dexamethasone induces an additive increase of analgesia that
might allow to reduce the doses of corticosteroids for the treatment of
pain and inflammation associated to diseases such as osteoarthritis.
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Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease
affecting the motor neurons of the spinal cord and brain. Degeneration
of spinal motor neurons leads to muscular atrophy and weakness
without accompanied sensory changes, whereas degeneration of motor
neurons in the cerebral cortex leads to hyper-reflexia. Because of its
rapid and progressive clinical course, ALS patients generally die within
2–5 years of onset. Matrix metallo proteinases (MMPs) are a relatively
large family of more than 20 Zn2+- containing, Ca2+-requiring endo-
peptidases, characterized by their ability to digest components of the
extracellularmatrix. Excessive expression ofMMPsmay result in tissue
damage. Therefore, precise control of the regulation of expression and
activity ofMMPs is important physiologically and pathologically. ALS
patients were selected using theWorld Federation of Neurology (WFN)
clinical criteria. Elisa kit for the estimation of MMP-9 was obtained
from R&D Systems, Minneapolis, MN, USA and was measured as per
the manufacturer’s specifications. Standard curve was prepared as per
the instructions and theMMP-9 levels were expressed as ng/ml. Results
show that the neuroinflammatorymarker,MMP-9 levels in the serum of
ALS patients were significantly (P\ 0.01) increased with respect to
control subjects and also showed significant correlation (R2 = 0.9)with
the duration of the disease. Neuroinflammation can both be a cause, and
a consequence of chronic oxidative stress which is produced by gluta-
mate excitotoxicity. Cytokine-stimulated microglia generate copious
amounts of reactive oxygen and reactive nitrogen species, creating a
stress upon ambient neurons. Conversely, oxidants can stimulate pro-
inflammatory gene transcription in glia, leading to various inflamma-
tory reactions including production of MMP-9.
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Introduction: N-Acetylaspartylglutamate (NAAG) is widely distrib-
uted peptide transmitter in the mammalian nervous system, activates
mGlu3 receptors at presynaptic sites which results to inhibit gluta-
mate release. Evidence suggests that glutamate receptors are involved
in inflammatory response carried through the COX-2 up regulation. In
present study we aimed to investigate the effect of NAAG
(10 mg kg-1) on carrageenan-induced acute inflammation.
Methods: Acute inflammation was induced by subplantar injection of
carrageenan 1% (w/v), in the right hind paw of the rats. The animals
received an intraperitoneal injection of NAAG 20 min before
induction of inflammation. The severity of inflammation was assessed
4 h later using maximum paw edema volume, Area Under Cur-
ve(AUC), microscopic changes of inflamed paw, measurement of
oxidative stress markers; myeloperoxidase(MPO), lipid peroxida-
tion(MDA level), SOD and GPx activity in paw tissue.
Results and conclusion: NAAG reduced maximum inflammatory
response and AUC by 52.56 and 58% (P\ 0.001), respectively,
compare to control. Microscopic studies indicated significant reduc-
tion in neutrophil infiltration. MPO activity in NAAG treated group
was inhibited by 80.19% (P\ 0.01) and MDA level was decreased
by 88.13% (P\ 0.01) compare to controls, but there were no sig-
nificant reduction in SOD and GPx activity. The results, for the first
time, suggest that NAAG may be involved in inhibiting peripheral
inflammation and it is possible that exerts this effect by modulating
systemic glutamate levels.
Keywords: N-acetylaspartylglutamate, inflammation,
myeloperoxidase, carrageenan.
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Nitric oxide (NO) is an important signaling messenger with a broad
range of functions in both the central and peripheral nervous sys-
tems. In the skin, NO is involved in vasodilation, melanogenesis,
and immune/inflammatory processes. NO is synthesized from L-
arginine by 3 isoforms of NO synthase (NOS)—neuronal NOS
(nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS).
Keratinocytes constitutively express nNOS and can be induced to
express iNOS by inflammatory cytokines. Preliminary studies using
human immortalized keratinocytes (hTERT) demonstrates that iNOS
is induced in a time- and dose-dependent manner by UVB and
cytokines such as CGRP, substance P, and VIP. To extend these
findings, we selected primary cortical neurons as a primary culture
paradigm with cellular lineage distinct from keratinocytes. Expres-
sion of all NOS isoforms following neuropeptide treatment (24 vs.
48 h) was assessed by Western blot. Primary cortical neurons were
treated in vitro with the nociceptive neurotransmitter substance P or
bicyclic monoterpene diols (BMTd) reported to increase NO levels
in neural crest-derived cells and compared to neurons that received
brain-derived neurotrophic factor (BDNF, 100 ng/ll), a growth
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